Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 37.43% is 15% below its 5-year average of 44.04%, near the low end of its 5-year range (36.67%–53.20%).
As of the fiscal period ended Tuesday, June 30, 2026. 13.70% below its 12-month average of 43.37%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 37.43%.
DEBT TO ASSETS RATIO
37.43%
DEBT TO ASSETS RATIO AVG TTM
43.37%
DEBT TO ASSETS RATIO AVG 3Y
46.88%
DEBT TO ASSETS RATIO AVG 5Y
44.04%
DEBT TO ASSETS RATIO AVG 10Y
36.49%
DEBT TO ASSETS RATIO AVG 15Y
28.25%
DEBT TO ASSETS RATIO AVG 20Y
22.09%
CURRENT VS TTM AVG
-13.70%
CURRENT VS 3Y AVG
-20.17%
CURRENT VS 5Y AVG
-15.00%
CURRENT VS 10Y AVG
+2.58%
CURRENT VS 15Y AVG
+32.49%
CURRENT VS 20Y AVG
+69.44%
SECTOR MEDIAN · HEALTHCARE
0.11%
median of 532 covered companies
CURRENT VS SECTOR MEDIAN
+35546.46%
vs the sector median at left
Cerus Corporation
Market Cap
$479.63M
Debt to Assets Ratio
37.43%
TTM Avg
43.37%
3Y Avg
46.88%
5Y Avg
44.04%
Market Cap
$487.55M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$462.36M
Debt to Assets Ratio
0.03%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$459.09M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cerus Corporation (CERS) | $479.63M | 37.43% | 43.37% | 46.88% | 44.04% |
| Bright Minds Biosciences Inc. (DRUG)vs › | $487.55M | 0.00% | N/A | N/A | N/A |
| Evolus, Inc. (EOLS)vs › | $479.42M | 0.66% | N/A | N/A | N/A |
| Arvinas, Inc. (ARVN)vs › | $475.84M | 0.01% | N/A | N/A | N/A |
| NeoGenomics, Inc. (NEO)vs › | $491.93M | 0.33% | N/A | N/A | N/A |
| NRC Health (NRC)vs › | $473.72M | 0.66% | N/A | N/A | N/A |
| Kamada Ltd. (KMDA)vs › | $463.63M | 0.03% | N/A | N/A | N/A |
| Contineum Therapeutics, Inc. (CTNM)vs › | $462.36M | 0.03% | N/A | N/A | N/A |
| DiaMedica Therapeutics Inc. (DMAC)vs › | $459.09M | 0.00% | N/A | N/A | N/A |
| Allogene Therapeutics, Inc. (ALLO)vs › | $512.56M | 0.13% | N/A | N/A | N/A |
Debt/Assets
37.4%
Debt/Equity
1.10
Current Ratio
1.83
Interest Coverage
-1.0x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 37.43% |
| 2026-03-31 | 43.68% |
| 2025-12-31 | 43.70% |
| 2025-09-30 | 45.63% |
| 2025-06-30 | 46.42% |
| 2025-03-31 | 48.09% |
| 2024-12-31 | 48.82% |
| 2024-09-30 | 51.65% |
| 2024-06-30 | 53.20% |
| 2024-03-31 | 53.19% |
| 2023-12-31 | 47.31% |
| 2023-09-30 | 46.11% |
| 2023-06-30 | 44.26% |
| 2023-03-31 | 42.97% |
| 2022-12-31 | 40.00% |
| 2022-09-30 | 40.60% |
| 2022-06-30 | 40.64% |
| 2022-03-31 | 39.90% |
| 2021-12-31 | 36.88% |
| 2021-09-30 | 37.61% |
| 2021-06-30 | 36.67% |
| 2021-03-31 | 37.51% |
| 2020-12-31 | 30.21% |
| 2020-09-30 | 29.83% |
| 2020-06-30 | 29.63% |
| 2020-03-31 | 29.73% |
| 2019-12-31 | 38.93% |
| 2019-09-30 | 50.40% |
| 2019-06-30 | 47.52% |
| 2019-03-31 | 45.25% |
| 2018-12-31 | 18.27% |
| 2018-09-30 | 18.47% |
| 2018-06-30 | 19.65% |
| 2018-03-31 | 20.65% |
| 2017-12-31 | 30.33% |
| 2017-09-30 | 30.67% |
| 2017-06-30 | 20.92% |
| 2017-03-31 | 21.38% |
| 2016-12-31 | 18.72% |
| 2016-09-30 | 16.66% |
| 2016-06-30 | 16.48% |
| 2016-03-31 | 15.50% |
| 2015-12-31 | 14.25% |
| 2015-09-30 | 14.69% |
| 2015-06-30 | 13.14% |
| 2015-03-31 | 6.90% |
| 2014-12-31 | 12.07% |
| 2014-09-30 | 12.42% |
| 2014-06-30 | 12.81% |
| 2014-03-31 | 4.46% |
| 2013-12-31 | 4.04% |
| 2013-09-30 | 4.58% |
| 2013-06-30 | 2.61% |
| 2013-03-31 | 7.54% |
| 2012-12-31 | 15.79% |
| 2012-09-30 | 16.91% |
| 2012-06-30 | 16.08% |
| 2012-03-31 | 13.89% |
| 2011-12-31 | 15.91% |
| 2011-09-30 | 13.43% |
| 2011-06-30 | 10.32% |
| 2011-03-31 | 9.80% |
| 2010-12-31 | 10.16% |
| 2010-09-30 | 15.15% |
| 2010-06-30 | 16.24% |
| 2010-03-31 | 13.74% |
| 2009-12-31 | 0.07% |
| 2009-09-30 | 0.06% |
| 2009-06-30 | 0.00% |
| 2009-03-31 | 0.00% |
| 2008-12-31 | 0.00% |
| 2008-09-30 | 0.02% |
| 2008-06-30 | 0.03% |
| 2008-03-31 | 0.03% |
| 2007-12-31 | 0.04% |
| 2007-09-30 | 0.04% |
| 2007-06-30 | 0.07% |
| 2007-03-31 | 0.09% |
| 2006-12-31 | 0.10% |
| 2006-09-30 | 0.16% |
| 2006-06-30 | 0.18% |
| 2006-03-31 | 0.22% |
| 2005-12-31 | 8.46% |
| 2005-09-30 | 8.34% |
| 2005-06-30 | 7.90% |
| 2005-03-31 | 7.28% |
| 2004-12-31 | 38.21% |
| 2004-09-30 | 62.42% |
| 2004-06-30 | 57.43% |
| 2004-03-31 | 0.01% |
| 2003-12-31 | 47.15% |
| 2003-09-30 | 41.44% |
| 2003-06-30 | 36.69% |
| 2003-03-31 | 48.92% |
| 2002-12-31 | 0.07% |
| 2002-09-30 | 0.07% |
